KASINGER JAMES R. (General Counsel and Secretary) sold 2.4% of their position (2.11K shares) of CRISPR THERAPEUTICS AG on the open market
Open‑market sale worth $111.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/20/2026ACC: 0001193125-26-061710
Officer· General Counsel and Secretary
Since Feb 2026
-2.11K
Net shares
Net seller
$111.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.83K acquired · 5.94K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+3.83K
Price / share
—
Trade value
—
% of position
4.6%
2/18/2026
83.40K→87.23K
Common Shares
Direct
Shares
−2.11K
Price / share
$52.58
Trade value
$111.05K
% of position
2.4%
2/19/2026
87.23K→85.11K
Total
Net shares
+1.71K
Net value
-$111.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 2/18/2026 | M · Option Exercise | +3.83K | — | — | 4.6% | 83.40K | 87.23K |
| Common Shares Direct | 2/19/2026 | S · Sale | −2.11K | $52.58 | $111.05K | 2.4% | 87.23K | 85.11K |
| Total | +1.71K | -$111.05K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Shares
3.83K shares
Shares
−3.83K
Strike price
Held after
0.00
Exercisable
—
2/18/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Shares3.83K shares | 2/18/2026 | M · Option Exercise | −3.83K | — | 0.00 |